CD4 and primary cutaneous T-cell non-Hodgkin lymphoma: The fact that malignant CD4+ T cells appear to be more sensitive to UVA1 radiation-induced apoptosis than normal CD4+ T cells supports the convenience of this treatment in the management of cutaneous T-cell lymphomas [32].